| Year |
Citation |
Score |
| 2008 |
Brody JR, Williams TK, Witkiewicz A, Cozzitorto J, Pasternack G, Kadkol S, Yeo CJ. M1858 pp32 Is a Key Regulator of Cellular Differentiation: Implications for Anti-Cancer Therapy Gastroenterology. 134: A-877. DOI: 10.1016/S0016-5085(08)64112-8 |
0.552 |
|
| 2007 |
Brody JR, Witkiewicz A, Williams TK, Kadkol SS, Cozzitorto J, Durkan B, Pasternack GR, Yeo CJ. Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasia. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 20: 1238-44. PMID 17906614 DOI: 10.1038/Modpathol.3800974 |
0.597 |
|
| 2005 |
Adegbola O, Pasternack GR. A pp32-retinoblastoma protein complex modulates androgen receptor-mediated transcription and associates with components of the splicing machinery. Biochemical and Biophysical Research Communications. 334: 702-8. PMID 16009334 DOI: 10.1016/J.Bbrc.2005.06.153 |
0.662 |
|
| 2005 |
Adegbola O, Pasternack GR. Phosphorylated retinoblastoma protein complexes with pp32 and inhibits pp32-mediated apoptosis. The Journal of Biological Chemistry. 280: 15497-502. PMID 15716273 DOI: 10.1074/Jbc.M411382200 |
0.671 |
|
| 2004 |
Hong R, Macfarlan T, Kutney SN, Seo SB, Mukai Y, Yelin F, Pasternack GR, Chakravarti D. The identification of phosphorylation sites of pp32 and biochemical purification of a cellular pp32-kinase. Biochemistry. 43: 10157-65. PMID 15287743 DOI: 10.1021/Bi0493968 |
0.325 |
|
| 2004 |
Kochevar GJ, Brody JR, Kadkol SS, Murphy KM, Pasternack GR. Identification of a functional mutation in pp32r1 (ANP32C). Human Mutation. 23: 546-51. PMID 15146458 DOI: 10.1002/Humu.20030 |
0.569 |
|
| 2004 |
Brody JR, Kadkol SS, Hauer MC, Rajaii F, Lee J, Pasternack GR. pp32 reduction induces differentiation of TSU-Pr1 cells. The American Journal of Pathology. 164: 273-83. PMID 14695340 DOI: 10.1016/S0002-9440(10)63117-3 |
0.609 |
|
| 2001 |
Kadkol SS, El Naga GA, Brody JR, Bai J, Gusev Y, Dooley WC, Pasternack GR. Expression of pp32 gene family members in breast cancer. Breast Cancer Research and Treatment. 68: 65-73. PMID 11678310 DOI: 10.1023/A:1017919507109 |
0.56 |
|
| 2001 |
Bai J, Brody JR, Kadkol SS, Pasternack GR. Tumor suppression and potentiation by manipulation of pp32 expression. Oncogene. 20: 2153-60. PMID 11360199 DOI: 10.1038/Sj.Onc.1204294 |
0.635 |
|
| 1999 |
Kadkol SS, Brody JR, Pevsner J, Bai J, Pasternack GR. Correction to "Modulation of oncogenic potential by alternative gene use in human prostate cancer" Nature Medicine. 5: 1087. PMID 10471270 DOI: 10.1038/12530 |
0.572 |
|
| 1999 |
Brody JR, Kadkol SS, Mahmoud MA, Rebel JM, Pasternack GR. Identification of sequences required for inhibition of oncogene-mediated transformation by pp32. The Journal of Biological Chemistry. 274: 20053-5. PMID 10400610 DOI: 10.1074/Jbc.274.29.20053 |
0.596 |
|
| 1999 |
Kadkol SS, Brody JR, Pevsner J, Bai J, Pasternack GR. Modulation of oncogenic potential by alternative gene use in human prostate cancer. Nature Medicine. 5: 275-9. PMID 10086381 DOI: 10.1038/6488 |
0.609 |
|
| 1998 |
Kadkol SS, Brody JR, Epstein JI, Kuhajda FP, Pasternack GR. Novel nuclear phosphoprotein pp32 is highly expressed in intermediate- and high-grade prostate cancer. The Prostate. 34: 231-7. PMID 9492852 DOI: 10.1002/(Sici)1097-0045(19980215)34:3<231::Aid-Pros11>3.0.Co;2-F |
0.64 |
|
| 1997 |
Pizer ES, Kurman RJ, Pasternack GR, Kuhajda FP. Expression of fatty acid synthase is closely linked to proliferation and stromal decidualization in cycling endometrium. International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists. 16: 45-51. PMID 8986532 DOI: 10.1097/00004347-199701000-00008 |
0.343 |
|
| 1996 |
Gusev Y, Romantsev FE, Chen TT, Kayler AE, Kuhajda FP, Dooley WC, Pasternack GR. pp32 overexpression induces nuclear pleomorphism in rat prostatic carcinoma cells. Cell Proliferation. 29: 643-53. PMID 9146727 DOI: 10.1111/J.1365-2184.1996.Tb00978.X |
0.409 |
|
| 1996 |
Chen TH, Brody JR, Romantsev FE, Yu JG, Kayler AE, Voneiff E, Kuhajda FP, Pasternack GR. Structure of pp32, an acidic nuclear protein which inhibits oncogene-induced formation of transformed foci. Molecular Biology of the Cell. 7: 2045-56. PMID 8970164 DOI: 10.1091/Mbc.7.12.2045 |
0.577 |
|
| 1994 |
Kuhajda FP, Jenner K, Wood FD, Hennigar RA, Jacobs LB, Dick JD, Pasternack GR. Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proceedings of the National Academy of Sciences of the United States of America. 91: 6379-83. PMID 8022791 DOI: 10.1073/Pnas.91.14.6379 |
0.331 |
|
| 1992 |
Shurbaji MS, Kuhajda FP, Pasternack GR, Thurmond TS. Expression of oncogenic antigen 519 (OA-519) in prostate cancer is a potential prognostic indicator. American Journal of Clinical Pathology. 97: 686-91. PMID 1374214 DOI: 10.1093/Ajcp/97.5.686 |
0.423 |
|
| 1991 |
Shurbaji MS, Pasternack GR, Kuhajda FP. Expression of haptoglobin-related protein in primary and metastatic breast cancers. A longitudinal study of 48 fatal tumors. American Journal of Clinical Pathology. 96: 238-42. PMID 1862779 DOI: 10.1093/Ajcp/96.2.238 |
0.373 |
|
| 1990 |
Pasternack GR, Racusen RH. Erythrocyte protein 4.1 binds and regulates myosin. Proceedings of the National Academy of Sciences of the United States of America. 86: 9712-6. PMID 2532361 DOI: 10.1073/Pnas.86.24.9712 |
0.309 |
|
| 1989 |
Kuhajda FP, Piantadosi S, Pasternack GR. Haptoglobin-related protein (Hpr) epitopes in breast cancer as a predictor of recurrence of the disease. The New England Journal of Medicine. 321: 636-41. PMID 2475778 DOI: 10.1056/Nejm198909073211003 |
0.397 |
|
| Show low-probability matches. |
